approved EB-1A

Computational Scientist

Computational Biology · China · 2025-01-24

Processing Time
59 days
Decision Date
2025-01-24
Location
Pennsylvania
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Framework Evaluation

3 of 3 criteria met
Scholarly Articles (Met)

The petitioner published 20 peer-reviewed articles in high-impact venues.

Judging (Met)

The petitioner completed 17 peer review assignments for prestigious journals.

Original Contributions (Met)

The petitioner developed machine learning models for drug discovery that garnered 1,642 citations and supported a startup's $27M funding round.

Why This Petition Was Approved

The petitioner submitted evidence of 20 peer-reviewed publications and 1,642 citations, placing him in the top 1% of his field. He also demonstrated his authority through 17 peer review invitations and research funding from the NSF, NIGMS, and DTRA. The case was approved after a successful NOID response emphasizing the broad implementation of his AI models and their impact on a startup that secured $27 million in financing.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Judging Experience
Grants
Original Contributions
Commercial Success
Evidence Submitted
  • 20 peer-reviewed articles (19 journal articles, 1 conference paper)
  • 1,642 citations from researchers in 74 countries
  • Top 1% of most highly cited authors in drug design over the past five years
  • 17 peer review invitations for prestigious journals
  • Research funding from National Science Foundation (NSF)
  • Research funding from National Institute of General Medical Sciences (NIGMS)
  • Research funding from Defense Threat Reduction Agency (DTRA)
  • AI platform foundation for a startup that secured $27 million in financing

Similar Cases

Scientist

Pharmaceuticals · China

WeGreened EB-1A approved
Massachusetts 21 days 2025-05-29
The petition was approved based on the satisfaction of at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of the work of others, and original scientific contributions of major significance. Specific metrics included 8 peer-reviewed publications in elite journals like Nature Microbiology, 260 citations placing him in the top 1% of his field, and the completion of over 20 peer reviews for high-impact journals.

Research Scientist

Artificial Intelligence · China

WeGreened EB-1A approved
Maryland 207 days 2025-10-14
The petition was approved based on 11 peer-reviewed articles and 2 preprints with 236 citations, placing several papers in the top 10% of the field. The petitioner satisfied EB-1A criteria through 11 peer reviews for leading journals, serving as an area chair for an international AI conference, and participating in federal grant reviews. His work on AI transparency and reliability was also recognized for its alignment with U.S. government regulatory initiatives.

Scientist

Pharmaceuticals · India

WeGreened EB-1A approved
Massachusetts 410 days 2025-10-06
The petition was approved based on the petitioner's authorship of 27 peer-reviewed articles and 17 abstracts, which garnered 485 citations from researchers in over 40 countries. His work ranked in the top 10% of most-cited publications in pharmacology for several years. Additionally, he completed over 60 peer reviews and received research grants from the NIH and the National Research Foundation of South Korea.

Others

Biotechnology · United Kingdom

WeGreened EB-1A approved
20 days 2025-12-09
The petition was approved based on the satisfaction of at least three EB-1A criteria, including scholarly articles, judging, and original contributions of major significance. Specific metrics included 8 peer-reviewed journal articles, 904 citations, and 15 peer review assignments for influential AI and computational venues. The case was strengthened by evidence of competitive funding from the Bill & Melinda Gates Foundation and Roche GmbH.

Frequently Asked Questions

A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-24.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 59 days
Criteria Met 3 / 3
Evidence Types 6

EB-1A Case Data

Scraped Case Data

Total Cases 919
Success Rate 53.0%
Sustained 487
Dismissed 315

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist